Comprehensive Medical Guide to Tuberculosis (TB)

Overview

Tuberculosis (TB) is an infectious disease caused primarily by the bacterium Mycobacterium tuberculosis. It most commonly affects the lungs (pulmonary TB) but can involve almost any organ (extrapulmonary TB). TB spreads through airborne droplets when a person with active pulmonary disease coughs, sneezes, or talks. Most infections remain latent—meaning the bacteria are present but the person has no symptoms and is not contagious. When the immune system cannot contain the bacteria, latent infection can progress to active disease. (References: CDC, Mayo Clinic)

Symptoms Checklist

Typical signs of active pulmonary TB include:

• Persistent cough lasting > 3 weeks
• Chest pain or discomfort
• Unexplained weight loss
• Night sweats
• Fever (often low‑grade)
• Fatigue or weakness
• Blood‑tinged sputum (hemoptysis)

Extrapulmonary TB may present with organ‑specific symptoms, such as lymph node swelling, abdominal pain, or meningitis signs.

Risk Factors

• Close contact with someone who has active TB
• Living or working in congregate settings (e.g., prisons, shelters, nursing homes)
• Immunocompromised states – HIV infection, organ transplantation, cancer chemotherapy, diabetes
• Substance use – tobacco, alcohol, illicit drugs
• Malnutrition or low body weight
• Travel or residence in regions with high TB prevalence (e.g., parts of Asia, Africa, Eastern Europe)

These factors increase the likelihood of acquiring infection or progressing from latent to active disease. (Reference: CDC)

Diagnosis

Diagnosing TB involves a combination of clinical assessment, imaging, and laboratory tests:

1. Medical History & Physical Exam – evaluation of symptoms, exposure risk, and risk‑factor review.
2. Chest Radiograph (X‑ray) – looks for infiltrates, cavitations, or nodules typical of pulmonary TB.
3. Sputum Microscopy – acid‑fast bacilli (AFB) stain to detect mycobacteria.
4. Sputum Culture – gold standard; grows the organism and allows drug‑susceptibility testing (takes 2‑8 weeks).
5. Nucleic Acid Amplification Tests (NAAT) – rapid molecular tests (e.g., GeneXpert) that detect TB DNA and rifampin resistance within hours.
6. Interferon‑Gamma Release Assays (IGRAs) or Tuberculin Skin Test (TST) – identify latent TB infection.
7. Additional Imaging – CT scan or MRI for extrapulmonary disease.

Guidelines from the WHO and CDC recommend confirming active disease with at least one positive microbiologic test or a combination of clinical and radiographic findings. (References: CDC, NIH)

Treatment Options

TB treatment requires prolonged antibiotic therapy to eradicate the slow‑growing bacteria and prevent resistance.

Standard Drug Regimen (Drug‑Sensitive TB)

• Intensive Phase (2 months): Isoniazid (INH) + Rifampin (RIF) + Pyrazinamide (PZA) + Ethambutol (EMB).
• Continuation Phase (4–7 months): Isoniazid + Rifampin.

All drugs are taken daily (or 3‑times‑weekly under directly observed therapy, DOT). Total therapy duration is usually 6 months.

Drug‑Resistant TB

• Multidrug‑resistant TB (MDR‑TB) – resistant to INH and RIF; treated with second‑line agents (e.g., fluoroquinolones, injectable aminoglycosides) for 18–24 months.
• Extensively drug‑resistant TB (XDR‑TB) – additional resistance to fluoroquinolones and at least one injectable; requires individualized regimens often including newer drugs like bedaquiline or delamanid.

Adjunctive & Home Care Measures

• Ensure adequate nutrition and hydration.
• Vitamin D supplementation may support immune function (consult provider).
• Use a mask (e.g., surgical mask) while coughing until sputum conversion is documented.
• Adhere strictly to medication schedule; missed doses increase resistance risk.
• Regular follow‑up labs to monitor liver function (INH, RIF, PZA) and visual acuity (EMB).

For detailed regimen charts, see the CDC TB Treatment Guidelines.

Prevention

• Vaccination: Bacille Calmette‑Guérin (BCG) vaccine – provides variable protection against severe childhood TB; not routinely used in the U.S.
• Screening & Treatment of Latent Infection: Isoniazid or Rifampin (or combined) for 3–9 months reduces risk of progression by >90%.
• Infection Control:
  • Airborne isolation for patients with suspected/confirmed pulmonary TB.
  • Negative‑pressure rooms, UV germicidal irradiation, and N95 respirators for healthcare workers.
• Public Health Measures: Prompt reporting, contact tracing, and DOT programs.
• Lifestyle: Smoking cessation, limiting alcohol, maintaining good nutrition, and managing chronic diseases (e.g., diabetes).

Information adapted from the World Health Organization and CDC.

Living With Tuberculosis (TB)

Managing TB successfully involves medical, emotional, and practical strategies:

• Medication Adherence: Use pillboxes, alarms, or mobile apps; consider DOT if adherence is challenging.
• Monitor Side Effects: Report nausea, visual changes, rash, or persistent fatigue to your provider promptly.
• Nutrition: Aim for a balanced diet rich in protein, fruits, vegetables, and whole grains; consider a dietitian referral.
• Physical Activity: Light to moderate exercise as tolerated; avoid strenuous activity if you feel fatigued.
• Social Support: Join support groups (online or community) and keep open communication with family and employers.
• Work & School: Most people become non‑contagious after 2 weeks of effective therapy; discuss accommodations with your employer or school.
• Follow‑up Appointments: Attend all scheduled sputum tests, chest X‑rays, and lab monitoring.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:

• Sudden worsening of shortness of breath or chest pain.
• High fever (> 101 °F / 38.3 °C) that does not improve with antipyretics.
• Severe coughing with large amounts of blood (hemoptysis).
• Signs of meningitis – severe headache, neck stiffness, confusion, or seizures (possible TB meningitis).
• Signs of drug toxicity – jaundice, dark urine, severe abdominal pain, vision loss, or rash.

Medical Disclaimer: This guide is for informational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personalized care. The content reflects current knowledge as of the publication date and may not include the latest research or guidelines.